Coronavirus Infections: all 952 studies

Page 6 of 10. Open to participants first (50), then studies with results posted, then the rest; newest registration first within each.

• Efficacy of Intravenous Melatonin on Mortality in Adult Patients Admitted to the Intensive Care Unit With COVID-19CompletedNCT04568863Phase 2
• COVID-19 BiorepositoryActive, not recruitingNCT04568148
• Corona Virus Infection Among Liver Transplant RecipientsStatus unknownNCT04565782
• An Observational Study of Neurologic Function After COVID-19 InfectionCompletedNCT04564287
• Nitazoxanide Therapy for Patients With COVID-19 PneumoniaCompletedNCT04561219Phase 2
• Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical VentilationCompletedNCT04558476Phase 2
• COVID-19 and Lactating MothersCompletedNCT04558320
• imPulse™ Una Full-spectrum, Over Clothing E-stethoscopeCompletedNCT04556149
• CoViD-19 Patient in Reims University Hospital in March to April 2020CompletedNCT04553575
• Effects of Early Use of Nitazoxanide in Patients With COVID-19CompletedNCT04552483Phase 2
• Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old)Status unknownNCT04550351Phase 1
• A Study to Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19)CompletedNCT04547127Phase 2
• COVID-19-Related Health and Practices Among Dental HygienistsCompletedNCT04542915
• The Impact of Premorbid Illnesses on the Risk of ICU Admission and Short-term OutcomeCompletedNCT04542538
• COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing ResidentsWithdrawnNCT04542395Not applicable
• Impact of Colchicine in Hospitalized Colombian Patients With COVID-19TerminatedNCT04539873Phase 3
• Salivary SARS-CoV-2 Load of Covid-19 Patients After Oral Antimicrobial Solutions and DentifricesCompletedNCT04537962Not applicable
• Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDSTerminatedNCT04536350Phase 2
• Vitamin D for COVID-19 TrialCompletedNCT04536298Phase 3
• A Study of a Candidate COVID-19 Vaccine (COV003)Status unknownNCT04536051Phase 3
• Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 PatientsCompletedNCT04535856Phase 1
• Taste and Smell Impairment in Critically Ill COVID-19 PatientsCompletedNCT04532632
• CORE Study COVID-19Status unknownNCT04531202
• COVID-19 Health Professional Impact StudyCompletedNCT04527432Not applicable
• Detecting SARS-CoV-2 in TearsCompletedNCT04526769
• High Dose Vitamin-D Substitution in Patients With COVID-19: a Randomized Controlled, Multi Center StudyCompletedNCT04525820Not applicable
• MOIST Study: Multi-Organ Imaging With Serial Testing in COVID-19 Infected PatientsCompletedNCT04525404
• Prediction Models for Diagnosis and Prognosis of Severe COVID-19CompletedNCT04525287
• Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home ResidentsCompletedNCT04523246Early Phase 1
• Prospective Hospital Registry of Patients With Suspected or Confirmed Coronavirus Infection (COVID-19) and Community-acquired PneumoniaActive, not recruitingNCT04522076
• CSL324 in COVID-19WithdrawnNCT04519424Phase 2
• Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic EventsStatus unknownNCT04519398
• Daily Regimen of Tenofovir/Emtricitabine as Prevention for COVID-19 in Health Care Personnel in ColombiaStatus unknownNCT04519125Phase 2/3
• Renal Biomarkers in AKI and COVID-19CompletedNCT04517630
• Characteristics in Post Covid-19 PatientsActive, not recruitingNCT04514705Not applicable
• COVID-19: Epidemiological Study of the Spread of SARS-CoV-2 in the Household of a Person Who Has Had a COVID-19 DiseaseCompletedNCT04511949Not applicable
• COVID-19 in Immunosuppressed ChildrenStatus unknownNCT04511429
• Host Response Mediators in Coronavirus (COVID-19) InfectionStatus unknownNCT04510623
• Canakinumab in Patients With COVID-19 and Type 2 DiabetesCompletedNCT04510493Phase 3
• Artificial Intelligence-assisted Diagnosis and Prognostication in COVID-19 Using ElectrocardiogramsStatus unknownNCT04510441
• The McMaster Multi-Regional COVID-19 Hospital Case RegistryStatus unknownNCT04508959
• Burden for STaff Working in the NHSActive, not recruitingNCT04506632
• The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19CompletedNCT04505761Not applicable
• Mental Health Status and Related Factors Among Physical Medicine & Rehabilitation Physicians in the Covid-19 PandemicStatus unknownNCT04500652
• Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDSCompletedNCT04494386Phase 1/2
• HYPONATREMIA IN COVID-19 PATIENTSCompletedNCT04493268
• Evaluation of Systemic and Oral Conditions of Pregnant Women and Their Babies, With Exposure to COVID-19 InfectionStatus unknownNCT04492449
• COVID-19 Infection and Multiple MyelomaCompletedNCT04492371
• COVID-19 Seroprevalence Study in French GuianaCompletedNCT04490850Not applicable
• Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Placebo to Treat Acute Pulmonary Inflammation Due to COVID-19WithdrawnNCT04490486Phase 1
• Can Remote Photoplethysmography Be Used for Contactless Vital Sign Acquisition in a Healthcare Setting? A Prospective Comparative Study.Status unknownNCT04489407Not applicable
• Anti-IL6 and Corticosteroid Monotherapy vs Combination in COVID-19Status unknownNCT04486521
• Assessing the Impact of the COVID-19 Lockdown on Metabolic Control and Access to Health Care in Patients With DiabetesStatus unknownNCT04485351
• Trial of Combination Therapy to Treat COVID-19 InfectionCompletedNCT04482686Phase 1
• Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831Status unknownNCT04480333Phase 1
• The Change of Critical Patient Managements and Subsequent Influences Under Epidemic of Coronavirus Disease 19 (COVID-19)CompletedNCT04479332Not applicable
• Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19TerminatedNCT04477993Phase 2/3
• Long-Term Experience and Health Effects of COVID-19CompletedNCT04477902
• Nitric Oxide Therapy for COVID-19 Patients With Oxygen RequirementCompletedNCT04476992Phase 1/2
• Comparison of Tocilizumab Plus Dexamethasone vs. Dexamethasone for Patients With Covid-19CompletedNCT04476979Phase 2
• Stress Related Disorders in Family Members of COVID-19 Patients Admitted to the ICUCompletedNCT04476914
• Enzalutamide Treatment in COVID-19TerminatedNCT04475601Phase 2
• Online Survey on Psychological Impact of COVID-19 Epidemic on School-age ChildrenStatus unknownNCT04475484
• GlitazOne Treatment for Coronavirus HypoxiA, a Safety and Tolerability Open Label With Matching Cohort Pilot StudyCompletedNCT04473274Phase 4
• Efficacy of Iodine Complex Against COVID-19 PatientsStatus unknownNCT04473261Phase 1/2
• Epidemiologic Assessment of SARS-CoV-2 (COVID-19) Prevalence in MinnesotaWithdrawnNCT04473183
• Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 PatientsStatus unknownNCT04472585Phase 1/2
• Seroprevalence of Coronavirus Disease 2019 (COVID-19) Antibodies in a Vulnerable Neighbourhood, Buenos Aries ArgentinaCompletedNCT04472078
• Physiotherapy as a Complimentary Treatment in Reducing Viral-Load, Complications, Death, Expedite Discharge and Improve Quality of Life, Exercise Endurance and Capacity in Stroke Survivors With CoViD-19: A Clinical-Controlled StudyStatus unknownNCT04471831Not applicable
• Evaluating Clinical Parameters of COVID-19 in PregnancyStatus unknownNCT04470583
• A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19CompletedNCT04469621Phase 1
• To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 PatientsStatus unknownNCT04468646Phase 3
• Characteristics of TraceTogether UsersCompletedNCT04468581
• Evaluation of an Alternative Method of Obtaining Viral RNA for the Detection of SARS-CoV-2 Virus Using PCRStatus unknownNCT04468217
• Clinical Study of Recombinant Novel Coronavirus VaccineStatus unknownNCT04466085Phase 2
• Arrhythmic Manifestations and Management in Hospitalized COVID-19 PatientsCompletedNCT04465552
• A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in AdultsWithdrawnNCT04464460Phase 1
• Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical ConditionsStatus unknownNCT04462848Phase 1
• Northeast COVID-19 and Pregnancy Study GroupActive, not recruitingNCT04462367
• Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare WorkersStatus unknownNCT04461379Phase 3
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate in Healthy Adult VolunteersCompletedNCT04461353Phase 1
• A Study of Combination Therapies to Treat COVID-19 InfectionWithdrawnNCT04459702Phase 2
• Psychiatric Disturbances and COVID-19 InfectionCompletedNCT04459403
• PHenotyping patiENts Admitted to Hospital With cOvid-19 Infection and idenTifYing Prognostic markErsStatus unknownNCT04459351
• Tigerase® Efficacy and Safety as Part of Complex Therapy in Patients With COVID-19CompletedNCT04459325Phase 3
• Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (CANADA Trial)WithdrawnNCT04456088Phase 2
• Monovalent Recombinant COVID19 VaccineCompletedNCT04453852Phase 1
• At Home Monitoring for Patients With Covid19CompletedNCT04453774Not applicable
• The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 ComplicationsStatus unknownNCT04453748
• The CASCADE Study - Measures of Complement Activation and Inflammation in Patients With Covid-19CompletedNCT04453527
• Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19)Status unknownNCT04452942
• Hesperidin and Diosmin for Treatment of COVID-19Status unknownNCT04452799Early Phase 1
• NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 InfectionStatus unknownNCT04452565Phase 2/3
• Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years.CompletedNCT04450004Phase 1
• Knowledge, Attitude and Practice of Dental Students About COVID-19CompletedNCT04449081
• Epidemiological Study of Seroprevalence Against the SARS-CoV-2 Virus (COVID-19)CompletedNCT04448769Not applicable
• The Impact of COVID-19 Outbreak on Trans-population's Health in ItalyCompletedNCT04448418
• Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19CompletedNCT04447781Phase 1/2
• Self-sampling for the Study of COVID-19CompletedNCT04447495
• Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 InfectionTerminatedNCT04447235Phase 2

← Coronavirus Infections overview